| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 02/21/2007 | CN1915980A Method for preparing analogue of carnosine |
| 02/21/2007 | CN1915979A Ion liquid of containing anisomerous dicentric positive ion, and preparation method |
| 02/21/2007 | CN1915968A Neutral-cationic lipid for nucleic acid and drug delivery |
| 02/20/2007 | US7179925 for aliphatic, aromatic, heterocycle aromatic compounds |
| 02/20/2007 | US7179912 Materials and methods to potentiate cancer treatment |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179829 Such as trans-(2-chloro-6-trifluoromethylphenyl)-(octahydrobenzimidazol-2-ylidene)amine hydrochloride; for treatment/prophylaxis of central nervous system disorders, lipid metabolism, infection by ectoparasites, disorders of gall function, improving respiratory drive/snoring |
| 02/20/2007 | US7179825 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | CA2085192C Fungicidal derivatives of 2-imidazoline-5-ones and 2-imidazoline-5-thiones |
| 02/15/2007 | WO2007018067A1 Transition metal complex compound and organic electroluminescent device using same |
| 02/15/2007 | WO2007017734A1 Carbon-nitrogen bond forming process |
| 02/15/2007 | WO2007017284A2 Inhibitors of cancer cell, t-cell and keratinocyte proliferation |
| 02/15/2007 | WO2006134219A3 Atipamezhole hydrochloride crystallization method |
| 02/15/2007 | WO2005123703A8 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 02/15/2007 | US20070037976 Method for producing an optically active nitro compound |
| 02/15/2007 | US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 02/15/2007 | US20070036718 Radiolabelled phenylethyl imidazole carboxylic acid ester derivatives |
| 02/15/2007 | CA2618750A1 Inhibitors of cancer cell, t-cell and keratinocyte proliferation |
| 02/15/2007 | CA2617520A1 Carbon-nitrogen bond forming process |
| 02/14/2007 | EP1752451A1 Bisguanidine-compound optical resolver and separating agent for chiral molecule |
| 02/14/2007 | EP1752450A1 Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them |
| 02/14/2007 | EP1751131A1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles |
| 02/14/2007 | EP1750691A2 Compounds for treatment of aids and other diseases |
| 02/14/2007 | CN1914181A Method for producing ionic liquids |
| 02/14/2007 | CN1913886A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
| 02/14/2007 | CN1911904A 2-substituted rubrene compound and its synthesis method and application |
| 02/14/2007 | CN1300156C Method for the separation of acids from chemical reaction mixtures by means of ionic fluids |
| 02/14/2007 | CN1300117C Microwave radiation synthesis of 1,3-substituted imidazole-2-thioketone |
| 02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176227 Amine compounds and use thereof |
| 02/13/2007 | US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved |
| 02/08/2007 | WO2007015805A1 1-amino linked compounds |
| 02/08/2007 | WO2007015533A1 Amidine compound and herbicide |
| 02/08/2007 | WO2007014619A1 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 02/08/2007 | WO2007014607A1 Quadratic acid derivatives in the form of a protein kinase inhibitors |
| 02/08/2007 | WO2006110477A3 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 02/08/2007 | US20070032655 Stable polymorph of flibanserin |
| 02/08/2007 | US20070032654 1-(2-(4-(3-trifluoromethyl-phenyl)piperazin-1-yl) ethyl)-2,3-dihydro-1H-benzimidazol-2-one (flibanserin); useful for treating psychological and nervous system disorders; prepared by heating a benzimidazolone compound with a piperazine derivative |
| 02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
| 02/08/2007 | US20070032536 Compounds, compositions and methods |
| 02/08/2007 | DE102005035103A1 Producing onium tetrafluoroborates useful as ionic liquids comprises reacting an onium halide with a trialkyloxonium, trialkylsulfonium or triphenylcarbonium tetrafluoroborate |
| 02/08/2007 | DE102005032838A1 Mischung von Onium-Alkylsulfonaten und Onium-Alkylsulfiten Mixture of onium alkyl sulfonates and onium Alkylsulfiten |
| 02/08/2007 | DE102005032837A1 Verfahren zur Herstellung von Onium-Alkylsulfiten A process for the preparation of onium Alkylsulfiten |
| 02/08/2007 | CA2617282A1 Novel imidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 02/08/2007 | CA2616682A1 Squaric acid derivatives as protein kinase inhibitors |
| 02/08/2007 | CA2616510A1 Cycloalkyl amino-hydantoin compounds and use thereof for .beta.-secretase modulation |
| 02/07/2007 | EP1748989A2 Aryl sulfonamides |
| 02/07/2007 | EP1748767A1 Diarylalkanes as potent inhibitors of binuclear enzymes |
| 02/07/2007 | EP1501504B1 1-substituted imidazole derivatives as nos inhibitors |
| 02/07/2007 | EP1017680B1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
| 02/07/2007 | CN1910166A Heteroaryl-ureas and their use as glucokinase activators |
| 02/07/2007 | CN1910156A Malononitrile compound as pesticide |
| 02/07/2007 | CN1910147A Malononitrile compound and use thereof |
| 02/07/2007 | CN1910124A Distillation of ionic liquids |
| 02/07/2007 | CN1907975A Electric dipole type functional molecule material |
| 02/07/2007 | CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 02/06/2007 | US7173139 Enantioselective 1,4-addition of aromatic nucleophiles to α,β-unsaturated aldehydes using chiral organic catalysts |
| 02/06/2007 | US7173057 Compounds as enzyme inhibitors to treat hepatitis with viricides |
| 02/06/2007 | US7173053 effective against the growing number of resistant bacteria, particularly the vancomycin resistant enterococci and beta -lactam antibiotic-resistant bacteria, such as methicillin-resistant Staphylococcus aureus |
| 02/06/2007 | US7173052 Resorcinol for lightening skin removing color |
| 02/06/2007 | US7173044 Imidazoline derivatives having CB1-antagonistic activity |
| 02/06/2007 | US7173035 Arylsulfonamide compounds |
| 02/06/2007 | US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 02/01/2007 | WO2007013694A1 Phenoxyalkanoic acid compound |
| 02/01/2007 | WO2007013421A1 Novel nitrogenated heterocyclic compound |
| 02/01/2007 | WO2007012670A2 Compounds derived from 5-benzylidene imidazolidine 2,4-dione and their use as mchr-1 antagonists |
| 02/01/2007 | US20070027326 Process for the manufacture of an enantiopure compound |
| 02/01/2007 | US20070027324 Process for producing 5-substituted oxazole compounds and 5-substituted imidazole compounds |
| 02/01/2007 | US20070027158 High affinity small molecule C5a receptor modulators |
| 01/31/2007 | EP1747203A1 Scalable synthesis of imidazole derivatives |
| 01/31/2007 | EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 01/31/2007 | EP1303541A4 Gel compositions containing metronidazole |
| 01/31/2007 | CN1906183A N-acylsulfonamide apoptosis promoters |
| 01/31/2007 | CN1903846A Ornidazole derivative used for therapy, its preparation method and use |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/31/2007 | CN1297535C Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 01/30/2007 | US7169939 Linkers for donor dyes to acceptor dyes for energy transfer between dyes with fluorescence |
| 01/30/2007 | US7169937 use for regulating the degree of polymerization during the polymerization of monomers, such as homo- or copolymerization of chloroprene and/or dichlorobutadiene |
| 01/30/2007 | US7169816 Phenylamino benzhydroxamic acid derivatives inhibit certain dual specificity kinase enzymes involved in proliferative diseases such as cancer, psoriasis and restenosis; inhibit the phosphorylation of MAP kinase by MEK |
| 01/30/2007 | US7169800 For cancer therapy |
| 01/25/2007 | WO2007011563A1 Derivatives of seleno-amino acids |
| 01/25/2007 | WO2007010222A2 Therapeutic agents |
| 01/25/2007 | WO2007009146A1 Substituted 1-phenyl imidazoles as cox-i inhibitors |
| 01/25/2007 | WO2006125592A3 Process for the preparation of 2-alkyl-1-((2'-substituted-biphenyl-4-yl)methyl)-imidazole, dihydroimidazole or benzimidazole derivatives |
| 01/25/2007 | WO2006117162A3 Method for impregnating lignocellulosic materials with effect agents |
| 01/25/2007 | WO2006065277A3 Heterocyclic aspartyl protease inhibitors |
| 01/25/2007 | US20070021606 Therapeutic compounds |
| 01/25/2007 | US20070021484 Substituted N-cinnamyl benzamides |
| 01/25/2007 | US20070021481 Anti-androgenic N-[ omega -[3-[4-cyano-3-(trifluoromethyl)-phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]alkyl]-substituted pyrrolidines; treatment of prostate cancer, benign prostate hyperplasia, androgenetic alopecia, hirsutism or acne |
| 01/25/2007 | US20070021426 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 01/25/2007 | US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/24/2007 | EP1745525A1 Material for electrolytic solution, ionic material-containing composition and use thereof |
| 01/24/2007 | EP1745289A2 Methods and antibodies for nitrofuran detection |
| 01/24/2007 | EP1472232B1 Processes for preparing imidazole derivatives and salts thereof |